Key result
Antibacterial envelopes reduce CIED infections ~45% vs standard care, primarily benefiting high-risk patients.
Why the study?
Prior meta-analyses of antimicrobial envelopes for preventing CIED infections were largely performed before contemporary cohorts and reported heterogeneous effects with limited exploration of effect-modifiers.
Does the use of absorbable antibiotic-eluting or antibacterial envelopes reduce major CIED infections in patients undergoing CIED implantation or revision?
Does the use of absorbable antibiotic-eluting or antibacterial envelopes reduce major CIED infections in patients undergoing CIED implantation or revision?
Antibacterial envelopes significantly reduce pocket-related CIED infections without altering systemic infection or mortality, supporting their selective use in high-risk patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Supports selective antibacterial envelope use in high-risk CIED patients; extends prior meta-analyses with updated contemporary evidence.
Background Antimicrobial envelopes are increasingly used to prevent cardiac implantable electronic device (CIED) infections, but prior meta‐analyses—performed largely before the accumulation of contemporary cohorts—reported heterogeneous effects and limited exploration of effect‐modifiers. Objective To update the evidence on antibacterial envelope effectiveness using contemporary studies and standardized infection definitions, and to quantify absolute and relative risk reductions across clinically relevant subgroups (device power, de novo vs. reintervention) with rigorous bias and robustness analyses. Methods We conducted a systematic review and meta‐analysis adhering to PRISMA. We included randomized and observational studies comparing absorbable antibiotic‐eluting or antibacterial envelopes versus standard care at CIED implantation or revision. “Major CIED infection” was prespecified per international consensus criteria. We used Mantel–Haenszel random‐effects models, prespecified subgroup analyses, leave‐one‐out sensitivity analyses, and GRADE. Risk of bias was assessed with RoB2/ROBINS‐I. Results Seven studies (13,306 patients; one randomized trial, six observational cohorts) met inclusion criteria. Antibacterial envelope use significantly reduced overall CIED infection (OR 0.55, 95% CI 0.33–0.92; p = 0.02), driven by a marked reduction in pocket infections (OR 0.32, 95% CI 0.19–0.52; p < 0.01). Systemic infection (OR 1.33, 95% CI 0.46–3.81; p = 0.60) and all‐cause mortality (OR 0.83, 95% CI 0.59–1.19; p = 0.32) were not significantly affected. Benefits were most pronounced in high‐risk subgroups. Conclusion Antibacterial envelopes substantially reduce pocket‐related CIED infections without altering systemic infection or mortality. These findings support their selective use in patients at elevated risk, particularly those undergoing generator replacement, pocket revision, or CRT implantation.
Papadopoulos et al. (2026) studied this question. Antibacterial envelopes reduced overall CIED infections by 45% and pocket infections by 68%, primarily benefiting high-risk patients.
Synapse has enriched 10 related papers. Consider them for comparative context: